Correlation Between Heron Therapeuti and Cannabics Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Heron Therapeuti and Cannabics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Heron Therapeuti and Cannabics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Heron Therapeuti and Cannabics Pharmaceuticals, you can compare the effects of market volatilities on Heron Therapeuti and Cannabics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Heron Therapeuti with a short position of Cannabics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Heron Therapeuti and Cannabics Pharmaceuticals.

Diversification Opportunities for Heron Therapeuti and Cannabics Pharmaceuticals

-0.08

Correlation Coefficient

Heron Therapeuti  Cannabics Pharmaceuticals

Good diversification

The 3 months correlation between Heron and Cannabics is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Heron Therapeuti and Cannabics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabics Pharmaceuticals and Heron Therapeuti is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Heron Therapeuti are associated (or correlated) with Cannabics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabics Pharmaceuticals has no effect on the direction of Heron Therapeuti i.e., Heron Therapeuti and Cannabics Pharmaceuticals go up and down completely randomly.

Pair Corralation between Heron Therapeuti and Cannabics Pharmaceuticals

Given the investment horizon of 90 days Heron Therapeuti is expected to generate 1.34 times less return on investment than Cannabics Pharmaceuticals. But when comparing it to its historical volatility, Heron Therapeuti is 3.59 times less risky than Cannabics Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Cannabics Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  1.00  in Cannabics Pharmaceuticals on October 27, 2024 and sell it today you would earn a total of  0.00  from holding Cannabics Pharmaceuticals or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Heron Therapeuti  vs.  Cannabics Pharmaceuticals

Heron Therapeuti

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Heron Therapeuti are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Heron Therapeuti showed solid returns over the last few months and may actually be approaching a breakup point.

Cannabics Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cannabics Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent fundamental drivers, Cannabics Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Heron Therapeuti and Cannabics Pharmaceuticals

The main advantage of trading using opposite Heron Therapeuti and Cannabics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Heron Therapeuti position performs unexpectedly, Cannabics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabics Pharmaceuticals will offset losses from the drop in Cannabics Pharmaceuticals' long position.

The idea behind Heron Therapeuti and Cannabics Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.